King Hussein Cancer Centre

What King Hussein Cancer Centre does

King Hussein Cancer Centre (KHCC) is a non-profit, comprehensive cancer treatment center headquartered in Amman, Jordan, founded in 2001 and operating as part of the dual-entity King Hussein Cancer Foundation and Center (KHCF/KHCC). It treats adult and pediatric cancer patients from Jordan, the broader Arab world, and internationally, delivering the five primary oncology modalities — chemotherapy, radiotherapy (with six linear accelerators), hormone therapy, bone marrow transplantation (the largest BMT program in the Middle East at up to 300 procedures annually), and surgical oncology (including Jordan's first robotic surgery system, a neurosurgery suite with intraoperative MRI, laser-based robotic brain tumor treatment, and first-in-region NanoKnife irreversible electroporation). Supporting infrastructure includes the Cell Therapy and Applied Genomics (CTAG) lab (Jordan's only public umbilical cord stem cell bank), a six-linear-accelerator radiation oncology department, advanced diagnostic imaging, early detection, and an AHA-affiliated Life Support Training Center.

KHCC generates revenue through a hybrid model typical of large non-profit medical institutions: treatment services to patients (insurance, out-of-pocket, and charity-subsidized), the Cancer Care Insurance (CCI) subscription program providing guaranteed cancer coverage to members, donations and fundraising (Goodwill Funds, Zakat, Sadaqa Jariyah, monthly giving, machinery and equipment philanthropy), and training and education programs for medical students, residents, and fellows at defined per-day rates (e.g., 30-70 JOD for students, 20-35 JOD for residents/fellows). Customer segmentation spans adult and pediatric patients, international Arab-world medical tourists served through a dedicated International Patient Services Office, CCI subscribers, and underprivileged patients funded via charitable programs. KHCC is governed by a Board of Trustees chaired by HRH Princess Ghida Talal, with Dr. Asem Mansour as CEO and Director General.

The center is differentiated by a stack of international accreditations including JCI (since 2006, first disease-specific cancer center in the developing world), FACT for BMT/cellular therapy, CAP laboratory accreditation, ANCC Magnet Recognition (first specialized cancer center outside the US), and AAHRPP for clinical research, supported by 36 partnerships with leading global cancer centers (MD Anderson, St. Jude, Princess Máxima, Princess Margaret, Institut Curie, Moffitt, NCI). KHCC has treated over 70,000 patients since founding and currently manages 7,000+ new cases and 25,000 outpatient referrals annually. Strategic expansion is underway with the new Aqaba regional satellite (operational Q3 2024), the King Hussein Children's Cancer Center under construction through 2027, the 28,000 sqm Ambulatory Care and Research Laboratories Building (commissioning Q3 2025), and a Therapeutic Radiology Building introducing high-accuracy techniques new to Jordan.

Name

King Hussein Cancer Centre

Legal name

King Hussein Cancer Foundation and Center

Website

https://khcc.jo

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

King Hussein Cancer Centre is a non-profit, JCI-accredited comprehensive cancer hospital in Amman, Jordan, treating adult and pediatric patients from the Arab world via chemotherapy, radiotherapy, BMT, robotic surgery, and genomics, supported by 36 global partnerships and a non-profit insurance program.

Ownership category

akta.pro rank

Product category

Cancer Treatment Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Medical and Diagnostic Laboratories (6215), Diagnostic Imaging Centers (621512)

SIC

Services-Hospitals (8060), Services-Specialty Outpatient Facilities, Nec (8093), Services-Medical Laboratories (8071)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industry

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

Keywords

• Cancer treatment services
• Oncology care
• Bone marrow transplantation
• Radiation oncology
• Pediatric oncology

Headquarters

HQ city

Amman

HQ country

Jordan

HQ region

Middle East

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Infrastructure, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Treatment Services Revenue: Revenue from comprehensive cancer treatment services including chemotherapy, radiotherapy, surgery, and bone marrow transplantation for patients
2. Cancer Care Insurance: Non-profit insurance program providing guaranteed treatment coverage at KHCC for members diagnosed with cancer. Largest social non-profit cancer insurance in Jordan.
3. Donations and Fundraising: Local, regional, and international donations through various programs including Goodwill Funds, Zakat, Sadaqa Jariyah, and monthly donation programs
4. Training and Education Programs: Revenue from elective training programs, residency and fellowship programs for medical professionals

Pricing tiers

Go-to-market motion2 records

Distribution channels6 records

Marketing channels8 records

Core offering

KHCC is a comprehensive cancer treatment center providing care for all types of cancer in adults and children through five core treatment modalities: chemotherapy, radiotherapy, hormone therapy, bone marrow transplantation, and surgery. The center operates 108,700 sqm of clinical space across three buildings in Amman, staffed by 300+ oncologists and 1,100+ specialized oncology nurses, supported by advanced technologies including six linear accelerators, robotic surgery systems, and a Cell Therapy and Applied Genomics Lab.

Product overview

King Hussein Cancer Center (KHCC) operates as a comprehensive, integrated cancer care ecosystem centered around its flagship treatment facility in Amman, Jordan. The core offering is the main cancer center (established 2001) providing treatment across all cancer types for adults and children through five primary modalities: chemotherapy, radiotherapy (with six linear accelerators), hormone therapy, bone marrow transplantation (the largest BMT program in the Middle East), and surgical oncology (including the first robotic surgery system and neurosurgery suite in Jordan). Supporting the clinical services are specialized units including the Cell Therapy and Applied Genomics Lab (housing Jordan's first public umbilical cord stem cell bank), Early Detection Unit, and Life Support Training Center (AHA-affiliated). The center's affiliated foundation operates the Cancer Care Insurance program (social non-profit insurance), Machinery and Equipment donation program, and various fundraising initiatives. Research and education are supported through the Education and Training Academy (offering an MSc in Cancer Care Informatics), Research Training Programs, and the St. Jude Global/KHCC Regional Qualitative Research Center. Patient support extends through the Psychosocial Oncology Program including summer camp, back-to-school, and creative therapy programs. Strategic expansion includes new facilities in Aqaba, a dedicated pediatric cancer center, and an ambulatory care and research building.

Differentiator

Problem solved

Functional benefit

Brands

• Cancer Care Insurance (CCI): A non-profit insurance program providing guaranteed treatment coverage at KHCC for cancer diagnosis at a moderate annual subscription fee, welcoming all nationalities with no age limit.
• Siwar Al Hussein Volunteering Program
• King Hussein Award for Cancer Research

Products and services

• Chemotherapy Services Systemic cancer treatment using chemical agents to destroy cancer cells, administered by specialized oncology staff at KHCC for cancer patients.
• Radiotherapy Services Radiation oncology services with six linear accelerators fitted with X-ray tracking systems offering high-precision targeting of solid tumors by delivering real-time images, for adult and pediatric cancer patients.
• Hormone Therapy Cancer treatment method using hormones to inhibit cancer cell growth, offered as part of comprehensive cancer care at KHCC.
• Bone Marrow Transplantation (BMT) Program Largest bone marrow transplant program in the Middle East, capable of performing up to 300 procedures annually with cure rates comparable to international standards, FACT-accredited, for leukemia and blood disease patients.
• Surgical Oncology Surgical cancer treatment including the first robotic surgery system in Jordan and advanced neurosurgery suite with laser-based brain tumor treatment, for adult and pediatric cancer patients.
• Cancer Care Insurance (CCI) Non-profit social insurance program providing guaranteed cancer treatment coverage at KHCC for members diagnosed with cancer, with moderate annual subscription fee, open to all nationalities with no age limit. Largest social non-profit cancer insurance in Jordan.
• Machinery and Equipment Donation Program Donation program allowing supporters to fund specific machinery and equipment needs for KHCC, including patient care equipment ranging from 30 to over 5,000 JOD in value.
• Life Support Training Center First AHA-affiliated training center in Jordan, offering courses including BLS, ACLS, PALS, PERS, ECG interpretation, and Heart Saver First Aid CPR AED for healthcare professionals and community members.
• Cell Therapy and Applied Genomics (CTAG) Lab State-of-the-art laboratory providing personalized medicine through cellular therapy and genomics, home to the first and only public umbilical cord stem cell bank in Jordan for leukemia and blood disease patients requiring bone marrow transplants.
• Early Detection Unit Early cancer detection unit providing recommended screening tests for men and women by age, supporting early diagnosis and improved outcomes.
• Education and Training Academy Academy offering MSc Cancer Care Informatics, training center, library resources, and e-learning courses for medical professionals, supporting residency, fellowship, and elective training programs.
• Research Training Programs Research training programs including Center for Research Administration and Training, covering scientific writing, biostatistics, and introduction to clinical research for medical researchers.
• Psychosocial Oncology Program Comprehensive psychosocial support program including mental health services, clinical psychology for pediatric and adolescent patients, creative therapy for adults and children, summer camp, back-to-school program, and letters of hope program for cancer patients and families.
• St. Jude Global/KHCC Regional Qualitative Research Center (Qual Center) Regional center dedicated to advancing qualitative and mixed-methods research in pediatric and adolescent healthcare, focusing on cancer and hematological diseases, in collaboration with St. Jude Global.
• Cancer Control Office Office leading tobacco dependence treatment, smoke-free zone certification program, cancer awareness activities, and community outreach programs with the first CTTTP-accredited Tobacco Dependence Treatment Training Program outside the US.
• Medical Residency and Fellowship Programs Elective training programs for medical students (30 JOD/day national, 70 JOD/day international) and residents/fellows (20 JOD/day national, 35 JOD/day international), accredited by Arab Board for Health Specializations, ASHP, ANCC, and other bodies.

Quantifiable outcome

• Treated over 70,000 patients since founding in 2001
• +3 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

23 partnerships are on record, tiered core, regional and minor.

• MD Anderson Cancer Center, USAcoreStrategic or Co-development PartnerStrategic partnership with one of the world's leading cancer centers for knowledge exchange, research collaboration, and best practices in cancer treatment
• St. Jude Children's Research Hospital, USAcoreStrategic or Co-development PartnerPartnership with leading pediatric cancer research hospital including the SJG/KHCC Regional Qualitative Research Center for pediatric oncology research
• Princess Máxima Center for Pediatric Oncology, NetherlandscoreStrategic or Co-development PartnerPartnership with Europe's leading pediatric oncology center for research and training collaboration
• American University of Beirut Medical Center, LebanonregionalStrategic or Co-development PartnerRegional partnership with leading medical center in the Arab world for collaborative cancer care initiatives
• International Atomic Energy Agency (IAEA)coreStrategic or Co-development PartnerCollaboration with IAEA for radiation oncology standards and nuclear medicine practices in cancer treatment
• National Cancer Institute, USAcoreStrategic or Co-development PartnerPartnership with US National Cancer Institute for research collaboration and cancer treatment protocols
• Leeds Teaching Hospitals NHS Trust, UKregionalStrategic or Co-development PartnerUK partnership for cancer treatment knowledge exchange and professional training
• Princess Margaret Cancer Centre, CanadacoreStrategic or Co-development PartnerPartnership with leading Canadian cancer center for treatment protocols and research collaboration
• Institut Curie, FrancecoreStrategic or Co-development PartnerCollaboration with renowned French cancer research and treatment center for expertise sharing
• Moffitt Cancer Center, USAcoreStrategic or Co-development PartnerPartnership with US cancer center specializing in research and treatment for knowledge exchange
• DKFZ - German Cancer Research Center, GermanycoreStrategic or Co-development PartnerCollaboration with leading German cancer research institution for research and clinical trials
• Union for International Cancer Control (UICC), SwitzerlandcoreStrategic or Co-development PartnerMember of global cancer control organization for international collaboration and advocacy
• Organization of European Cancer Institutes (OECI), BelgiumcoreStrategic or Co-development PartnerMembership in European cancer institute network for quality standards and best practices
• The Champalimaud Foundation, PortugalregionalStrategic or Co-development PartnerPartnership with Portuguese foundation for cancer research and treatment collaboration
• European Organization for Research and Treatment of Cancer (EORTC), BelgiumcoreStrategic or Co-development PartnerCollaboration with European organization for clinical cancer research and treatment trials
• International Union for Targeted Cancer Therapy, FranceregionalStrategic or Co-development PartnerPartnership for targeted cancer therapy expertise and training
• An-Najah National University, PalestineregionalStrategic or Co-development PartnerAcademic partnership with Palestinian university for research and training collaboration
• Qatar Biomedical Research Institute, QatarregionalStrategic or Co-development PartnerRegional partnership for biomedical research in cancer treatment
• National Cancer Institute, EgyptregionalStrategic or Co-development PartnerRegional collaboration with Egyptian cancer institute for treatment protocols and research
• Jordanian Association of PsychiatristsregionalStrategic or Co-development PartnerCo-organization of mental health conferences supporting psychological care for cancer patients and Gaza crisis support
• JOPACC (Jordanian Palliative Care Society)regionalStrategic or Co-development PartnerAgreement to support early cancer detection project
• Jordan Kuwait BankminorGTM or Marketing PartnerStrategic agreement for banking and financial support services
• Bank Al-EtihadminorGTM or Marketing PartnerStrategic agreement for banking and financial support services

Scale indicators9 records

Recent moves10 records

Expansion highlights7 records

Direct peers

• MD Anderson Cancer Center: World-leading comprehensive cancer center based in Houston, Texas. KHCC maintains a strategic partnership with MD Anderson, and both deliver multidisciplinary oncology across surgery, chemotherapy, radiotherapy, and BMT, making MD Anderson the closest functional peer for KHCC's model.
• Memorial Sloan Kettering Cancer Center: Premier US cancer specialty hospital offering comprehensive adult and pediatric oncology services. Both institutions operate as dedicated, research-active cancer specialty hospitals serving high-acuity and international patient populations.
• St. Jude Children's Research Hospital: Leading pediatric oncology research and treatment hospital and KHCC's core partner via the SJG/KHCC Regional Qualitative Research Center. Operates the same combined clinical-research model for pediatric cancer that KHCC is scaling through its Children's Cancer Center build-out.
• King Faisal Specialist Hospital and Research Centre: Saudi Arabia's flagship specialty hospital and research center, operating comprehensive cancer programs including BMT. The closest geographic and functional peer in the GCC, competing with KHCC for regional medical tourism and donor capital.
• Institut Gustave Roussy: Europe's leading comprehensive cancer center located near Paris. Comparable in mission, scope (research + clinical across all tumor types), and international patient orientation, with KHCC citing Gustave Roussy's approach as part of its care model.
• Princess Margaret Cancer Centre: Canada's largest comprehensive cancer center and a KHCC strategic partner. Operates similar multidisciplinary specialty hospital model, advanced radiotherapy, and translational research programs.

Regional players

• Tata Memorial Hospital: India's premier government cancer specialty hospital. Comparable in providing high-volume, comprehensive cancer care and serving a regional catchment, though operating in a different geography with distinct payer dynamics.
• Sheikh Khalifa Medical City (SEHA): UAE government-operated tertiary hospital network including oncology services. A regional player with comparable scale in the GCC, partially overlapping with KHCC for inbound Arab-world patients.

Broad incumbents

• Cleveland Clinic: Large US-based multi-specialty health system with comprehensive cancer programs and an Abu Dhabi presence. Competes with KHCC for medical tourism in the broader Middle East but operates across many specialties rather than a pure-play oncology focus.
• Mayo Clinic: US-based integrated multi-specialty health system with major oncology service line and international patient program. Relevant comparable for KHCC's tertiary/quaternary care delivery model and international patient ambitions.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/khcfkhcc
• YouTubeyoutube.com/channel/UC7anPbxit123Pyz24_M084A
• Facebookfacebook.com/kinghusseincancerfoundationandcenter
• LinkedInlinkedin.com/company/king-hussein-cancer-center
• Instagraminstagram.com/kinghusseincancerfoundation

Compliance14 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles17 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about King Hussein Cancer Centre